lei zhang, MD
Chinese Academy of Medical Science and Blood Disease Hospital
19
19
3
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+6 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (19)
Showing 10 of 19 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yunfei Chen, MD
Chinese Academy of Medical Science and Blood Disease Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ellis Neufeld, MD
Boston Children's Hospital
Shared therapeutic areas:
Joseph Kiss, MD
University of Pittsburgh
Shared therapeutic areas:
David Kuter, MD
Massachusetts General Hospital
Shared therapeutic areas:
Judith Lin, MD
Brigham and Women's Hospital
Shared therapeutic areas:
Cindy Leissinger, MD
Tulane University
Shared therapeutic areas:
Terry Gernsheimer, MD
University of Washington
Shared therapeutic areas:
Thomas Ortel, MD
Duke University
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Worked with same sponsors:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (19)
Showing 19 of 19 trials
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
Anti-CD38 Antibody Treating APS With Thrombocytopenia
A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
Herombopag for Chemotherapy-induced Thrombocytopenia
A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
Avatrombopag for Chemotherapy-induced Thrombocytopenia
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Gene Therapy for Chinese Hemophilia A
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
All 19 trials loaded